A Prospective, Multicenter, Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination Of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s90. https://doi.org/10.25251/skin.4.supp.90